Press Releases

Greystone Pharmaceuticals, Inc. Announces Appointment of Chief Medical Director
April 28, 2007

Fort Myers, FL – Dermagenics U.S., Inc., a subsidiary of Greystone Pharmaceuticals, Inc. Click here for full press release.

Greystone Pharmaceuticals, Inc. and 3M Health Care announce supply and distribution agreement
3M to distribute product made by Greystone in the U.K.
April 19, 2007

Fort Myers, Florida – Greystone Pharmaceuticals, Inc. of Fort Myers, Florida, announced today that it has signed an agreement with 3M Health Care Limited of Loughborough, England for the supply and distribution of The Woundcare Company’s advanced wound care dressing, DerMax®, in the United Kingdom. Under the agreement, 3M Health Care Limited will brand and distribute DerMax in the U.K. The Woundcare Company's European wound care products subsidiary, Dermagenics Europe, BV, will manufacture the product for 3M. Click here for full press release.

New wound care technology debuted at international conference
Ostomy Wound Management
January 26, 2007

Greystone Pharmaceuticals, Inc. (Memphis, Tenn.), through its European subsidiary Dermagenics BV, announced the U.K. launch of its chronic wound technology — Epi-Max EU®.

Epi-Max EU® is noted for use as a wound dressing to manage diabetic ulcers, decubitus ulcers, leg ulcers, and acute severe wounds where fast epithelialization is required. This is the first wound care product permitted to claim the ability to downregulate matrix metalloproteinase production (MMP). Studies demonstrate this downregulation enhances chronic and acute severe wound healing.

The product is currently marketed and sold under the DerMax® name throughout Europe and the Middle East. Encouraged by the success of DerMax® throughout the continent, Dermagenics looks forward to presenting this state-of-the-art technology globally to provide the healthcare community with wound care alternatives that are effective in accelerating the wound healing process.

Epi-Max EU® made its United Kingdom debut at the Wounds U.K. International Conference held in Harrogate on November 13-15, 2006. The product, which has been approved for the Drug Tariff List, is now available for distribution.

Tennessee Medicare Health Support Program offers monitoring technologies, transportation services to participants
April 11, 2006

XLHealth, one of the nation's fastest-growing disease management companies, and Greystone Pharmaceuticals, Inc., an expert in the development of advanced patient monitoring technologies, have joined forces to facilitate access to health support services for participants in Tennessee's new Medicare Health Support program. Through this partnership, participants in the Medicare Health Support program, which is sponsored by the Centers for Medicare & Medicaid Services and operated in Tennessee by XLHealth, will be offered transportation services and state-of-the-art home health testing equipment as necessary. Click here for the full press release.

Greystone Pharmaceuticals, Inc. to expand into Lee County, Florida
March 14, 2006

Greystone Pharmaceuticals, Inc., a biotech development company specializing in medical devices and pharmaceutical products, has announced its decision to open a corporate headquarters for their holding company in Lee County, Florida. Click here for the full press release.

Dr. Moore wins award for research
September 9, 2005

Dr. Bob Moore was awarded the Health Care Innovations Award by the Memphis Business Journal for his hemostatic and hemorrhagic shock research. Click here for the University of Tennessee's press release.